SCM
PMVP icon

Stonepine Capital Management’s PMV Pharmaceuticals PMVP Stock Holding History

Stonepine Capital Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$718K Sell
536,086
-172,016
-24% -$221K 0.41% 57
2026
Q1 		$878K Sell
708,102
-442,657
-38% -$563K 0.35% 42
2025
Q4 		$1.44M Sell
1,150,759
-219,380
-16% -$294K 1.05% 28
2025
Q3 		$1.92M Buy
1,370,139
+524,171
+62% +$725K 1.56% 17
2025
Q2 		$897K Buy
845,968
+215,785
+34% +$212K 0.88% 29
2025
Q1 		$687K Buy
630,183
+94,378
+18% +$128K 0.67% 30
2024
Q4 		$809K Buy
+535,805
New +$849K 0.65% 33

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Stonepine Capital Management's PMVP Position: Q2 2026 in Review

Stonepine Capital Management reduced its PMV Pharmaceuticals (PMVP) stake by 24% in Q2 2026, selling an estimated $221K and leaving 536,086 shares worth $718K. The position accounts for 0.41% of the portfolio, ranked #57.

Stonepine Capital Management first reported a position in PMVP in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.92M in Q3 2025. 64 funds tracked by Wall St. Rank hold PMVP as of Q2 2026.

  • Stonepine Capital Management held 536,086 shares of PMV Pharmaceuticals worth $718K as of Q2 2026.
  • Stonepine Capital Management sold 172,016 PMV Pharmaceuticals shares in Q2 2026, an estimated $221K.
  • PMV Pharmaceuticals made up 0.41% of Stonepine Capital Management's portfolio in Q2 2026, its #57 holding.
  • Stonepine Capital Management first reported a position in PMV Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • Stonepine Capital Management's PMV Pharmaceuticals position peaked at $1.92M in Q3 2025.
  • 64 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2026.

Based on Stonepine Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.